Preliminary experience with drug-coated balloon angioplasty in primary percutaneous coronary intervention

Table 1 Baseline clinical characteristics, angiographic features, procedural data and clinical outcomes of patients n (%)

	n = 89
Mean age (yr)	59 ± 14
Male: female	74:15 (83:17)
Ever smokers	50 (56)
Diabetes	25 (28)
Hyperlipidemia	41 (46)
Hypertension	49 (55)
Previous myocardial infarction	9 (10)
LVEF	44% ± 11%
Presentation
Anterior MI	40 (45)
Inferior MI	49 (55)
Target vessel
LAD	33 (37)
CIRC	12 (13)
RCA	29 (33)
Others	15 (17)
Reference diameter, mm	2.4 ± 0.4
Thrombus aspiration	50 (56)
Predilatation with non-coated balloon	89 (100)
Glycoprotein 2b/3a inhibitors	71 (80)
TIMI flow
Post-procedural TIMI 2 flow	2 (2)
Post-procedural TIMI 3 flow	87 (98)
30-d clinical outcomes
Mortality	4 (4.5)
Target vessel revascularisation	0 (0)
Target vessel MI	0 (0)
Target lesion thrombosis	0 (0)

LVEF: Left ventricular ejection fraction; MI: Myocardial infarction; LAD: Left anterior descending artery; CIRC: Left circumflex artery; RCA: Right coronary artery; TIMI: Thrombolysis in myocardial infarction.